Your browser doesn't support javascript.
loading
Variability of definition of high-risk multiple myeloma across phase III clinical trials.
Abu Za'nouneh, Faris Jamal; Ababneh, Obada; Schinke, Carolina; Thanendrarajan, Sharmilan; Zangari, Maurizio; Shaughnessy, John D; Zhan, Fenghuang; van Rhee, Frits; Al Hadidi, Samer.
Afiliación
  • Abu Za'nouneh FJ; Faculty of Medicine Jordan University Of Science and Technology Irbid Jordan.
  • Ababneh O; Faculty of Medicine Jordan University Of Science and Technology Irbid Jordan.
  • Schinke C; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • Thanendrarajan S; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • Zangari M; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • Shaughnessy JD; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • Zhan F; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • van Rhee F; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
  • Al Hadidi S; Myeloma Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA.
EJHaem ; 4(2): 454-458, 2023 May.
Article en En | MEDLINE | ID: mdl-37206288

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: EJHaem Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: EJHaem Año: 2023 Tipo del documento: Article
...